Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University Comprehensive Cancer Center
Study ID
NCT03711890
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Optical Coherence Tomography — PROCEDURE
    Undergo OCT
  • Therapeutic Conventional Surgery — PROCEDURE
    Undergo resection will be undertaken
  • Laboratory Evaluation — DIAGNOSTIC_TEST
    Labs will be obtained to test for cancer cell derived exosomes

Study Details

This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.

Key Dates

Start date
Mar 26, 2019
Status verified
Jun 2026
Primary completion
Sep 15, 2026
Completion
Sep 15, 2026

Study Design

Enrollment
75 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Diagnostic (resection, OCT)
    Participants undergo resection. Resected tissues are analyzed via ultra-high resolution OCT.

Primary Outcome Measure

Measure accuracy of using OCT to diagnose pancreatic cancer and compare with histology. [ Time Frame: Up to 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ohio State University Comprehensive Cancer CenterColumbusOhio43210
Mary E. Dillhoff, MD
[email protected]
614-293-7171
Mary E. Dillhoff, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Columbus, OH

By condition
Pancreatic cancer
By specialty
OncologyGI oncology
By research site
Ohio State University Comprehensive Cancer Center· Columbus, OH

Related Studies